On the one hand, it has been shown that Nrf2 is upregulated in various cancers [172,173], which is caused either by DNA methylation in the promoter region of Keap1, constitutive Nrf2 activation, or mutations in the Keap1 domain [174,175]. This evidence concerns the gene NFE2L2 and cancer.